LUCD - Lucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Call Transcript

2024-03-26 16:27:08 ET

Lucid Diagnostics Inc. (LUCD)

Q4 2023 Earnings Conference Call

March 26, 2024, 08:30 AM ET

Company Participants

Lishan Aklog - Chairman and CEO

Dennis McGrath - CFO

Conference Call Participants

Kyle Mikson - Canaccord

Joseph Conway - Needham

Anthony Vendetti - Maxim Group

Vidyun Bais - BTIG

Ed Wood - Ascendiant Capital

Presentation

Operator

Good morning, and welcome to the Lucid Diagnostics Fourth Quarter and Full Year 2023 Business Update Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Dennis McGrath, Lucid Diagnostics' Chief Financial Officer. Please go ahead.

Dennis McGrath

Thank you, Ludy. Good morning, everyone. Thank you for participating in today's fourth quarter and full year 2023 Lucid Diagnostics business update call. The press release announcing our business update for the company and financial results for the fourth quarter and the year ending December 31, 2023, is available on our Lucid website. Please take a moment and read the disclaimer about forward-looking statements in the press release.

Business update, the press release and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the U.S. Securities and Exchange Commission.

For a list and description of these and other important risk factors and uncertainties that may affect future operations, see Part I, Item 1A entitled Risk Factors in Lucid's most recent annual report on Form 10-Q filed with the SEC and subsequent updates filed in quarterly reports on Form 10-Q and any subsequent filings on Form 8-K.

Except as required by law, Lucid disclaims any intentions or obligations to publicly update or revise any forward-looking statements to reflect changes in expectations or in events, conditions or circumstances on which the expectations may be based or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

I'd like to turn the call over to Dr. Lishan Aklog, our Chairman and CEO of Lucid Diagnostics. Lishan?

Lishan Aklog

Thank you, Dennis, and good afternoon, everyone. Thank you for joining our quarterly update call today. Before proceeding, a couple of things. First, I'd like to apologize, as I have a bit of a scratchy throat. I'm feeling under the weather. So sorry about that....

For further details see: